Table: Phoenixbio - 6-MTH group results

PhoenixBio

13/11/2020 06:30

Nov 13 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2020        Sep 30, 2019      Mar 31, 2021  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            301 mln             521 mln            1.35      
                 (-42.2 pct)         (+22.3 pct)       (+2.7 pct)   
  Operating     loss 288 mln        loss 165 mln       loss 50 mln  
  Recurring     loss 265 mln        loss 155 mln       loss 37 mln  
  Net           loss 267 mln        loss 156 mln       loss 39 mln  
  EPS          loss 83.98 yen      loss 53.54 yen    loss 12.23 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T